Predictive value of HbA1c for incident diabetes among subjects with impaired glucose tolerance-analysis of the Indian Diabetes Prevention Programmes

Diabetic Medicine

Volumn 29, Issue 1, 2012, Pages 94-98

  Ramachandran, A ^a   Snehalatha, C ^a   Samith Shetty, A ^a   Nanditha, A ^a  

^a Dr A Ramachandran's Diabetes Hospitals   (India)

Author keywords

HbA1c; Prediction; Prevention; Type2 diabetes

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; METFORMIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; ORAL GLUCOSE TOLERANCE TEST; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DIET RESTRICTION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INCIDENCE; INDIA; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION; STATISTICAL MODEL;

BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; INDIA; LOGISTIC MODELS; MALE; METFORMIN; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 83155182350     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03392.x     Document Type: Article

References (25)

1. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327-1334.
2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34: S62-S69.
3. Lu ZX, Walker KZ, O Dea K, Sikaris KA, Shaw JE. A1C for screening and diagnosis of type2 diabetes in routine clinical practice. Diabetes Care 2010; 33: 817-819.
4. Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES et al. the Diabetes Prevention Program Research Group Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007; 30: 2453-2457.
5. Eberhardt MS, Lackland DT, Wheeler FC, German RR, Teutsch SM. Is race related to glycemic control? As assessment of glycosylated hemoglobin in two South Carolina Communities. J Clin Epidemiol 1994; 47: 1181-1189.
6. Ziemer DC, Kolm P, Weintraub WS, Vaccarino V, Rhee MK, Twombly JG et al. Glucose-independent, Black-White differences in hemoglobin A1c levels. Ann Intern Med 2010; 152: 770-777.
7. Herman WH, Cohen RM. Hemoglobin A1c: teaching a new dog old tricks. Ann Intern Med 2010; 152: 815-817.
8. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V. Indian Diabetes Prevention Programme (IDPP). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006; 49: 289-297.
9. Ramachandran A, Snehalatha C, Mary S, Selvam S, Kumar CK, Seeli AC et al. Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2). Diabetologia 2009; 52: 1019-1026.
10. Ramachandran A, Samith Shetty A, Nanditha A, Snehalatha C. Efficacy of primary prevention interventions when fasting and postglucose dysglycemia coexist. Diabetes Care 2010; 33: 2164-2168.
11. Snehalatha C, Mary S, Selvam S, Sathish Kumar CK, Shetty SB, Nanditha A et al. Changes in insulin secretion and insulin sensitivity in relation to the glycemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1). Diabetes Care 2009; 32: 1796-1801.
12. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. PartI: Diagnosis and Classification of Diabetes Mellitus. WHO/NCD/NCS/99.2. Geneva: World Health Organization, 1999.
13. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostatis model assessment insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1958; 28: 412-419.
14. Wareham NJ, Philips DIW, Byrne CD, Hales CN. The 30-min insulin increase mental response in an OGTT as a measure of insulin secretion. Diabet Med 1995; 12: 931.
15. Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ. Utility of hemoglobin A1C in predicting diabetes risk. J Gen Intern Med 2004; 19: 1175-1180.
16. Sato KK, Hayashi T, Harita N, Yoneda T, Nakamura Y, Endo G et al. Combined measurement of fasting plasma glucose and A1C is effective for the prediction of type2 diabetes the Kansai Healthcare Study. Diabetes Care 2009; 32: 644-646.
17. 1c) predicts future drug treatment for diabetes mellitus: a follow-up study using routine clinical data in a Japanese university hospital. Transl Res 2007; 149: 196-204.
18. 1c in diagnosing and predicting type2 diabetes in impaired glucose tolerance: the Finnish Diabetes Prevention Study. Diabet Med 2011; 28: 36-42.
19. Kilpatrick ES, Rigby AS, Atkin SL. The effect of glucose variability on the risk of effect of glucose variability on the risk of microvascular complications in type1 diabetes. Diabetes Care 2006; 29: 1486-1490.
20. 1c as a screening tool for detection of Type2 diabetes: a systematic review. Diabet Med 2007; 24: 333-343.
21. 1c between 5.7 and 6.4% as a marker for identifying prediabetes, insulin sensitivity and secretion and cardiovascular risk factors: The Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 2010; 33: 2104-2109.
22. 1c cut points to define various glucose intolerance groups in Asian Indians. Diabetes Care 2010; 33: 515-519.
23. Kramer CK, Araneta MR, Barrett-Connor E. A1C and diabetes diagnosis: The Rancho Bernardo Study. Diabetes Care 2010; 33: 101-103.
24. Selvin E, Brancati FL, Steffes MW, Coresh J, Gregg E. Performance of A1C for the classification and prediction of diabetes. Diabetes Care 2011; 34: 84-89.
25. 1c measurement for the diagnosis of diabetes: is it enough? Diabet Med 2011; 28: 31-35.